Sequence information
Variant position: 102 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 533 The length of the canonical sequence.
Location on the sequence:
RFIRTDAYVRAMTEKRIVIT
E FGTCAFPDPCKNIFSRFFSY
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human RFIRTDAYVRAMTEKRIVITE FGTCAFPDPCKNIFSRFFSY
RFIRTDAYVRAMTEKRIVITE FGTCAFPDPCKNIFSRFFSY
Mouse RFIRTDAYVRAMTEKRIVITE FGTCAFPDPCKNIFSRFFSY
Rat RFIRTDAYVRAMTEKRIVITE FGTCAFPDPCKNIFSRFFSY
Bovine RFIRTDAYVRAMTEKRIVITE FGTCAFPDPCKNIFSRFFSY
Chicken RFVRTDAYVRAMTEKRIVITE FGTYAYPDPCKNIFSRFFSY
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
2 – 533
Retinoid isomerohydrolase
Modified residue
101 – 101
Phosphothreonine
Modified residue
105 – 105
Phosphothreonine
Modified residue
113 – 113
N6-acetyllysine
Modified residue
117 – 117
Phosphoserine
Lipidation
112 – 112
S-palmitoyl cysteine; in membrane form
Mutagenesis
106 – 106
C -> A. No loss of enzymatic activity. No effect on palmitoylation. No loss of membrane association.
Mutagenesis
106 – 106
C -> Y. Does not affect isomerohydrolase activity.
Mutagenesis
112 – 112
C -> A. Loss of enzymatic activity. No palmitoylation. Loss of membrane association.
Literature citations
Mutations in the RPE65 gene in patients with autosomal recessive retinitis pigmentosa or Leber congenital amaurosis.
Morimura H.; Fishman G.A.; Grover S.A.; Fulton A.B.; Berson E.L.; Dryja T.P.;
Proc. Natl. Acad. Sci. U.S.A. 95:3088-3093(1998)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS RP20 TRP-91; LYS-102; THR-132; SER-341; GLY-452 AND ASP-473;
Clinical and molecular genetics of Leber's congenital amaurosis: a multicenter study of Italian patients.
Simonelli F.; Ziviello C.; Testa F.; Rossi S.; Fazzi E.; Bianchi P.E.; Fossarello M.; Signorini S.; Bertone C.; Galantuomo S.; Brancati F.; Valente E.M.; Ciccodicola A.; Rinaldi E.; Auricchio A.; Banfi S.;
Invest. Ophthalmol. Vis. Sci. 48:4284-4290(2007)
Cited for: VARIANTS LCA2 PRO-22; VAL-70; PRO-91; LYS-102; ASP-144; TYR-167 AND ARG-313;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.